# A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)

> **NCT00968617** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 7 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease

## Interventions

- **DRUG:** MK2578
- **DRUG:** MK2578
- **DRUG:** MK2578
- **DRUG:** Comparator: darbepoetin alfa

## Key facts

- **NCT ID:** NCT00968617
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968617, "A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00968617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*